Q8, Q9, & Q10 Questions and Answers -- Appendix: Q&As from Training Sessions (Q8, Q9, & Q10 Points to Consider)
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 13, 2012
April 15, 2020
74f08aab-1b94-4f9f-8da0-2725af03d078
Related Documents
S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use
Guidance DocumentJune 7, 2012Center for Drug Evaluation and Research
E3 Structure and Content of Clinical Study Reports - Questions and Answers (R1)
Guidance DocumentJanuary 29, 2013Center for Drug Evaluation and Research
Q11 Development and Manufacture of Drug Substances
Guidance DocumentNovember 20, 2012Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.